Insulin-like growth factor 2 (IGF2) mRNA binding proteins (IGF2BPs/IMPs) have been described to be oncogenic in several types of cancer including pancreatic cancer [2,3,4,5,6,7]. The gene discussed is IGF2; the disease is pancreatic neoplasm.